drugset / Trial / NCT06149091

Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase

NCT06149091 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

A prospective national multi-center study will be conducted to evaluate the effectiveness of hemocoagulase in iatrogenic airway bleeding in a large class III hospital, such as the Second Affiliated Hospital of Harbin Medical University, the First Affiliated Hospital of Nanchang University, and to compare it with topical epinephrine and tranexamic acid in a prospective double-blind cluster randomized controlled trial.

Timeline

Start
2023-12-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified — Topical
Subject Hemagglutinase Unknown — Intravenous
Comparator Tranexamic Acid Small molecule — Topical

Indications